1. Home
  2. ITRM vs POM Comparison

ITRM vs POM Comparison

Compare ITRM & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.24

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

POM

POMDOCTOR LIMITED American Depositary Shares

N/A

Current Price

$0.24

Market Cap

26.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
ITRM
POM
Founded
2015
2015
Country
Ireland
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
26.5M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ITRM
POM
Price
$0.24
$0.24
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
612.9K
369.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
57.43
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$947.65
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.19
52 Week High
$1.49
$6.43

Technical Indicators

Market Signals
Indicator
ITRM
POM
Relative Strength Index (RSI) 38.23 34.60
Support Level N/A $0.21
Resistance Level $0.39 $0.27
Average True Range (ATR) 0.03 0.03
MACD -0.00 0.04
Stochastic Oscillator 32.07 73.61

Price Performance

Historical Comparison
ITRM
POM

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About POM POMDOCTOR LIMITED American Depositary Shares

Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.

Share on Social Networks: